Yang L, Liu Y, Wang C, Feng Z, Yu L, Pan J
Neoplasia. 2024; 57:101060.
PMID: 39357265
PMC: 11474188.
DOI: 10.1016/j.neo.2024.101060.
Serbis A, Tsinopoulou V, Papadopoulou A, Kolanis S, Sakellari E, Margaritis K
Diagnostics (Basel). 2023; 13(9).
PMID: 37174978
PMC: 10177772.
DOI: 10.3390/diagnostics13091588.
Teng Y, Ran X, Chen B, Chen C, Xu J
J Clin Med. 2022; 11(24).
PMID: 36556097
PMC: 9782822.
DOI: 10.3390/jcm11247481.
Feng Z, Li C, Cao L, Qiao N, Wu W, Bai J
Front Neurol. 2022; 13:847418.
PMID: 35481274
PMC: 9035929.
DOI: 10.3389/fneur.2022.847418.
Wu J, Wu X, Yang Y, Ding H, Yang L, Bao Y
Neurosurg Rev. 2021; 45(1):139-150.
PMID: 34159471
DOI: 10.1007/s10143-021-01563-9.
Aggressive Childhood-onset Papillary Craniopharyngioma Managed With Vemurafenib, a BRAF Inhibitor.
Chik C, van Landeghem F, Easaw J, Mehta V
J Endocr Soc. 2021; 5(5):bvab043.
PMID: 33928205
PMC: 8064044.
DOI: 10.1210/jendso/bvab043.
Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.
Feng Y, Ni M, Wang Y, Zhong L
Exp Ther Med. 2019; 17(1):51-56.
PMID: 30651764
PMC: 6307520.
DOI: 10.3892/etm.2018.6953.
Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.
Prieto R, Pascual J
Pituitary. 2018; 21(4):431-442.
PMID: 29700680
DOI: 10.1007/s11102-018-0890-6.
Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.
Coury J, Davis B, Koumas C, Manzano G, Dehdashti A
Neurosurg Rev. 2018; 43(1):41-48.
PMID: 29666970
DOI: 10.1007/s10143-018-0978-5.
Craniopharyngiomas : Radiological Differentiation of Two Types.
Lee I, Zan E, Bell W, Burger P, Sung H, Yousem D
J Korean Neurosurg Soc. 2016; 59(5):466-70.
PMID: 27651864
PMC: 5028606.
DOI: 10.3340/jkns.2016.59.5.466.
Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Muller H
Pituitary. 2016; 20(2):267-281.
PMID: 27604996
DOI: 10.1007/s11102-016-0751-0.
TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
Liu Y, Wang C, Li D, Zhang S, Peng Y, Peng J
Oncotarget. 2016; 7(31):50564-50574.
PMID: 27409178
PMC: 5226603.
DOI: 10.18632/oncotarget.10501.
Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model.
Stache C, Holsken A, Schlaffer S, Hess A, Metzler M, Frey B
Brain Pathol. 2014; 25(1):1-10.
PMID: 24716541
PMC: 8029249.
DOI: 10.1111/bpa.12148.
Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
Stache C, Holsken A, Fahlbusch R, Flitsch J, Schlaffer S, Buchfelder M
Neuro Oncol. 2013; 16(2):256-64.
PMID: 24305709
PMC: 3895384.
DOI: 10.1093/neuonc/not195.
Ectopic recurrence of a craniopharyngioma in a 15-year-old girl 9 years after surgery and conventional radiotherapy: case report.
Elfving M, Lundgren J, Englund E, Stromblad L, Erfurth E
Childs Nerv Syst. 2011; 27(5):845-51.
PMID: 21221975
DOI: 10.1007/s00381-010-1375-8.
Comparative immunohistochemical assessment of craniopharyngioma and related lesions.
Le B, Towfighi J, Kapadia S, Lopes M
Endocr Pathol. 2007; 18(1):23-30.
PMID: 17652797
DOI: 10.1007/s12022-007-0011-y.
Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features.
Gupta D, Ojha B, Sarkar C, Mahapatra A, Sharma B, Mehta V
Childs Nerv Syst. 2005; 22(1):50-5.
PMID: 15895298
DOI: 10.1007/s00381-005-1171-z.
Craniopharyngioma: a clinicopathological study of 141 cases.
Tavangar S, Larijani B, Mahta A, Hosseini S, Mehrazine M, Bandarian F
Endocr Pathol. 2005; 15(4):339-44.
PMID: 15681858
DOI: 10.1385/ep:15:4:339.
Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma.
Losa M, Vimercati A, Acerno S, Barzaghi R, Mortini P, Mangili F
J Neurol Neurosurg Psychiatry. 2004; 75(6):889-92.
PMID: 15146007
PMC: 1739047.
DOI: 10.1136/jnnp.2003.012781.
Regression of a large solid papillary craniopharyngioma following fractionated external radiotherapy.
Honegger J, Grabenbauer G, Paulus W, Fahlbusch R
J Neurooncol. 1999; 41(3):261-6.
PMID: 10359146
DOI: 10.1023/a:1006112600805.